Follow The Filings

FRHC Freedom

Freedom earnings company data as of 4:00 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by FRHC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All FRHC insider trades
  • $2.4M bought by 1 insider
  • $8M sold by 6 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Azamat Yerdessov Freedom Life Chief Exec. Ofc.
    Sale
    $520K 3,000 shares at $173.30 1.3% of stake
    Traded Aug 28 Filed Sep 1
    ↗
  2. Evgeny Ler CEO
    Sale
    $3.2M 20,000 shares at $158.63 51% of stake
    Traded Aug 19 Filed Sep 1
    ↗
  3. Valeriy Kim CFO
    Sale
    $847K 5,000 shares at $169.31 9.5% of stake
    Traded Aug 26 Filed Aug 28
    ↗
  4. Renat Tukanov Chief Technology Officer
    Sale
    $408K 2,700 shares at $151.25 27% of stake
    Traded Aug 13 Filed Aug 14
    ↗
  5. Boris Cherdabayev Director
    Sale
    $86K 636 shares at $135.85 84% of stake
    Traded Nov 4, 2025–Dec 29, 2025 Filed Jul 22
    ↗
  6. Renat Tukanov Chief Technology Officer
    Sale
    $253K 1,800 shares at $140.82 15% of stake
    Traded Jun 22 Filed Jun 24
    ↗
  7. Andrew Gamble Director
    Sale
    $50K 357 shares at $141.04 35% of stake
    Traded Jun 22 Filed Jun 24
    ↗
  8. Azamat Yerdessov Freedom Life Chief Exec. Ofc.
    Sale
    $2.6M 16,800 shares at $155.48 6.9% of stake
    Traded Jun 4 Filed Jun 8
    ↗
  9. Sergey Lukyanov *See Remarks
    Buy
    $2.4M 20,000 shares at $120.52 +15% to stake
    Traded Feb 24–25 Filed Feb 27
    ↗
  10. Andrew Gamble Director
    Sale
    $48K 400 shares at $119.39 53% of stake
    Traded Feb 12 Filed Feb 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 6 stock grants and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 3.02,7.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 7.01,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.